Clinical Trials Browser

Phase 1 × azeliragon × 90 days × Clear all

NCT06724926 2026-05-18

Concurrent Azeliragon With Craniospinal Irradiation

Phase 1 Active not recruiting

Glioma, Meningeal Carcinomatosis